DE602004025265D1 - Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon - Google Patents

Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon

Info

Publication number
DE602004025265D1
DE602004025265D1 DE200460025265 DE602004025265T DE602004025265D1 DE 602004025265 D1 DE602004025265 D1 DE 602004025265D1 DE 200460025265 DE200460025265 DE 200460025265 DE 602004025265 T DE602004025265 T DE 602004025265T DE 602004025265 D1 DE602004025265 D1 DE 602004025265D1
Authority
DE
Germany
Prior art keywords
phosphat
new
use
pharmaceutical compositions
binding protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE200460025265
Other languages
English (en)
Inventor
Eric Chabriere
Carlos Contreras-Martel
Juan Fontecilla-Camps
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Henri Poincare - Nancy I
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Henri Poincare - Nancy I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0312729A priority Critical patent/FR2861731B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Henri Poincare - Nancy I filed Critical Centre National de la Recherche Scientifique CNRS
Priority to PCT/FR2004/002797 priority patent/WO2005042572A1/fr
Publication of DE602004025265D1 publication Critical patent/DE602004025265D1/de
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes
DE200460025265 2003-10-30 2004-10-29 Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon Active DE602004025265D1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0312729A FR2861731B1 (fr) 2003-10-30 2003-10-30 Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations
PCT/FR2004/002797 WO2005042572A1 (fr) 2003-10-30 2004-10-29 Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations

Publications (1)

Publication Number Publication Date
DE602004025265D1 true DE602004025265D1 (de) 2010-03-11

Family

ID=34429758

Family Applications (1)

Application Number Title Priority Date Filing Date
DE200460025265 Active DE602004025265D1 (de) 2003-10-30 2004-10-29 Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon

Country Status (11)

Country Link
US (1) US7718773B2 (de)
EP (1) EP1678204B1 (de)
JP (1) JP4728246B2 (de)
CN (1) CN1898261B (de)
AT (1) AT455792T (de)
CA (1) CA2543935C (de)
DE (1) DE602004025265D1 (de)
ES (1) ES2341174T3 (de)
FR (1) FR2861731B1 (de)
IL (1) IL175319A (de)
WO (1) WO2005042572A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
CN103536914B (zh) 2005-12-29 2015-11-11 贝林格尔.英格海姆维特梅迪卡有限公司 多价pcv2免疫原性组合物和制备此类组合物的方法
EP2374475A1 (de) * 2005-12-29 2011-10-12 Boehringer Ingelheim Vetmedica, Inc. Verwendung einer immunogenen PCV2-Zusammensetzung zur Abschwächung von Krankheitssystemen bei Schweinen
WO2008064299A2 (en) * 2006-11-22 2008-05-29 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
WO2008073464A2 (en) 2006-12-11 2008-06-19 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
CN107412761A (zh) 2006-12-15 2017-12-01 贝林格尔.英格海姆维特梅迪卡有限公司 以pcv2抗原治疗猪
EP1941903A1 (de) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxe und Behandlung von PRDC
EP1958644A1 (de) * 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Vorbeugung und Behandlung von subklinischer PCVD
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
US20110020394A1 (en) * 2007-12-31 2011-01-27 Boehringer Ingelheim Vetmedica, Inc. Pcv2 orf2 virus like particle with foreign amino acid insertion
BRPI0907438A2 (pt) 2008-01-23 2015-08-04 Boehringer Ingelheim Vetmed Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições
FR2942717B1 (fr) * 2009-03-04 2011-08-12 Centre Nat Rech Scient Nouvel agent antiviral
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
WO2014014918A2 (en) * 2012-07-16 2014-01-23 St. Luke's-Roosevelt Hospital Center X-ding-cd4 peptide
EP3052516B1 (de) 2013-10-02 2020-01-01 Boehringer Ingelheim Animal Health USA Inc. Pcv2-orf2-proteinvariante und virusähnlichen partikel daraus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030158115A1 (en) * 2000-03-28 2003-08-21 Toback F. Gary Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells
CA2334905A1 (en) * 1998-06-12 1999-12-23 Gordon J. Hoover Pattern recognition proteins with lectin homology from several animal species and method to use them for measure or modulate innate resistance against bacteria and other pathogenic agents

Also Published As

Publication number Publication date
IL175319D0 (en) 2006-09-05
CN1898261B (zh) 2011-08-17
JP2008502305A (ja) 2008-01-31
IL175319A (en) 2013-07-31
FR2861731B1 (fr) 2006-02-24
ES2341174T3 (es) 2010-06-16
CA2543935A1 (fr) 2005-05-12
CA2543935C (fr) 2014-12-02
AT455792T (de) 2010-02-15
WO2005042572A1 (fr) 2005-05-12
EP1678204A1 (de) 2006-07-12
JP4728246B2 (ja) 2011-07-20
US7718773B2 (en) 2010-05-18
FR2861731A1 (fr) 2005-05-06
CN1898261A (zh) 2007-01-17
EP1678204B1 (de) 2010-01-20
US20070196879A1 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
TWI347313B (en) Novel substituted phenoxyacetic acids,pharmaceutical composition comprising them,and use thereof
DE50312295D1 (de) 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel
DK1587514T3 (da) Hurtigvirkende farmaceutisk præparat
DK1673063T3 (da) Transdermal farmaceutisk sammensætning
DE60230340D1 (de) N-Ä4-(4-Amino-2-ethyl-1H-imidazoÄ4,5-cÜchinolin-1-yl)butylÜmethanesulfonamide, diese enthaltende pharmazeutische Zusammensetzung und deren Verwendung
IL213597D0 (en) Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL175550A (en) Heterocyclic boronic acid compounds, mixtures thereof and pharmaceutical compositions comprising them
DE502004006904D1 (de) Carbazol-enthaltende konjugierte polymere und blends, deren darstellung und verwendung
EP1673343A4 (de) Verbindungen und zusammensetzungen als proteinkinaseinhibitoren
NL1025404A1 (nl) Pyrazolo-triazine verbindingen en gebruik daarvan.
IL178297D0 (en) Hydrazide derivatives and pharmaceutical compositions containing the same
BRPI0407755B1 (pt) composiÇço catalÍtica, sua preparaÇço e uso
DK1716145T3 (da) Dihydrotetrabenaziner og farmaceutiske præparater indeholdende disse
AT473731T (de) Zweischichtiges kosmetisches produkt , dessen verwendungen und kit für das schminken, das dieses produkt enthält
AT516288T (de) Pyrrolobenzodiazepinderivate, zusammensetzungen, die diese enthalten, und damit in zusammenhang stehende verfahren
IL166401D0 (en) Pharmaceutical compositions containing endothelialer
EP1670771A4 (de) Verbindungen und zusammensetzungen als proteinkinaseinhibitoren
IL170758D0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
DE602004006133D1 (de) Neue galactooligosaccharidzusammensetzung und herstellung davon
AU2003291103A8 (en) Pharmaceutical composition
IL171214A (en) Carbonyl compounds, their preparation and pharmaceutical compositions comprising them
DE60308851D1 (de) Proteinisolate, zusammensetzungen, die proteinisolate enthalten, und verfahren zu ihrer verwendung
IL173973A (en) (naphthalenyl-methyl)-azetidinecarboxylic acid, derivatives thereof and pharmaceutical compositions containing it
IL173602D0 (en) Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same
IL173627D0 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition